Marlina Tanty Ramli Hamid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marlina Tanty Ramli Hamid has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Kartini Rahmat
Department of Biomedical Imaging, Faculty of Medicine, University Malaya Research Imaging Centre, University Malaya, Lembah Pantai, Kuala Lumpur, 50603, Malaysia.
7 shared publications Kartini Rahmat
Department of Biomedical Imaging, University Malaya Research Imaging Centre, Kuala Lumpur, Malaysia
6 shared publications- Nazimah Ab Mumin
Affiliation Department of Radiology, Faculty of Medicine, University Teknologi MARA, Sungai Buloh, Selangor, Malaysia
5 shared publications Shamsiah Abdul Hamid
Affiliation Department of Radiology, Faculty of Medicine, University Teknologi MARA, Sungai Buloh, Selangor, Malaysia
5 shared publicationsWai Yee Chan
Department of Biomedical Imaging, University Malaya Research Imaging Centre, Kuala Lumpur, Malaysia | Department of Radiology, Gleneagles Hospital, Kuala Lumpur, Malaysia
4 shared publicationsJayalakshmi Pailoor
Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
2 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Apparent diffusion coefficient and intravoxel incoherent motion-derived true diffusion serve as early non-contrast longitudinal biomarkers of neoadjuvant chemotherapy response
Locally advanced breast cancer (LABC) frequently requires neoadjuvant chemotherapy (NAC), and early, non-contrast imaging biomarkers are of increasing clinical interest for monitoring treatment response. Diffusion-weighted imaging (DWI) and intravoxel incoherent motion (IVIM) MRI provide quantitative measures of tumour microstructure without gadolinium administration. To evaluate whether the apparent diffusion coefficient (ADC) and true diffusion (Dt) derived from IVIM can serve as early non-contrast imaging biomarkers of NAC response in patients with LABC. Fourteen women with biopsy-proven LABC underwent MRI at baseline (T0), after the first NAC cycle (T1), and after the third cycle (T2). ADC was calculated from b = 0 and 1000 s/mm², while Dt, Dp, and f were obtained using a full bi-exponential IVIM model incorporating all b-values (0–1000 s/mm²). Only four patients completed all three MRI timepoints. Tumour diameter and diffusion parameters were compared across time. At baseline, ADC and Dt were significantly lower in malignant lesions compared with contralateral fibroglandular tissue ( p < 0.01). Following NAC, mean tumour ADC increased by 27.2% at T1 and 39.5% at T2, accompanied by progressive tumour size reduction (50.9% at T2). Dt demonstrated a similar upward trend. Perfusion-related IVIM parameters (Dp and f) showed no consistent differences. ROC analysis demonstrated high discriminatory performance of ADC for differentiating invasive ductal carcinoma from normal tissue (AUC = 1.00), although this finding must be interpreted cautiously given the small sample size. ADC and Dt showed early increases following NAC that paralleled reductions in tumour size, supporting their potential as practical, contrast-free imaging biomarkers of treatment-related microstructural changes. However, the limited number of complete longitudinal datasets ( n = 4) and the pilot nature of the study require cautious interpretation. Larger prospective studies are needed to validate these findings.
- 21 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessApparent diffusion coefficient and intravoxel incoherent motion-derived true diffusion serve as early non-contrast longitudinal biomarkers of neoadjuvant chemotherapy response
Locally advanced breast cancer (LABC) frequently requires neoadjuvant chemotherapy (NAC), and early, non-contrast imaging biomarkers are of increasing clinical interest for monitoring treatment response. Diffusion-weighted imaging (DWI) and intravoxel incoherent motion (IVIM) MRI provide quantitative measures of tumour microstructure without gadolinium administration. To evaluate whether the apparent diffusion coefficient (ADC) and true diffusion (Dt) derived from IVIM can serve as early non-contrast imaging biomarkers of NAC response in patients with LABC. Fourteen women with biopsy-proven LABC underwent MRI at baseline (T0), after the first NAC cycle (T1), and after the third cycle (T2). ADC was calculated from b = 0 and 1000 s/mm², while Dt, Dp, and f were obtained using a full bi-exponential IVIM model incorporating all b-values (0–1000 s/mm²). Only four patients completed all three MRI timepoints. Tumour diameter and diffusion parameters were compared across time. At baseline, ADC and Dt were significantly lower in malignant lesions compared with contralateral fibroglandular tissue ( p < 0.01). Following NAC, mean tumour ADC increased by 27.2% at T1 and 39.5% at T2, accompanied by progressive tumour size reduction (50.9% at T2). Dt demonstrated a similar upward trend. Perfusion-related IVIM parameters (Dp and f) showed no consistent differences. ROC analysis demonstrated high discriminatory performance of ADC for differentiating invasive ductal carcinoma from normal tissue (AUC = 1.00), although this finding must be interpreted cautiously given the small sample size. ADC and Dt showed early increases following NAC that paralleled reductions in tumour size, supporting their potential as practical, contrast-free imaging biomarkers of treatment-related microstructural changes. However, the limited number of complete longitudinal datasets ( n = 4) and the pilot nature of the study require cautious interpretation. Larger prospective studies are needed to validate these findings.
- Open Access
- 7 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (5) , e0322925
Comparative analysis of diagnostic performance in mammography: A reader study on the impact of AI assistance
Purpose: This study evaluates the impact of artificial intelligence (AI) assistance on the diagnostic performance of radiologists with varying levels of experience in interpreting mammograms in a Malaysian tertiary referral center, particularly in women with dense breasts. Methods: A retrospective study including 434 digital mammograms interpreted by two general radiologists (12 and 6 years of experience) and two trainees (2 years of experience). Diagnostic performance was assessed with and without AI assistance (Lunit INSIGHT MMG), using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUC). Inter-reader agreement was measured using kappa statistics. Results: AI assistance significantly improved the diagnostic performance of all reader groups across all metrics (p < 0.05). The senior radiologist consistently achieved the highest sensitivity (86.5% without AI, 88.0% with AI) and specificity (60.5% without AI, 59.2% with AI). The junior radiologist demonstrated the highest PPV (56.9% without AI, 74.6% with AI) and NPV (90.3% without AI, 92.2% with AI). The trainees showed the lowest performance, but AI significantly enhanced their accuracy. AI assistance was particularly beneficial in interpreting mammograms of women with dense breasts. Conclusion: AI assistance significantly enhances the diagnostic accuracy and consistency of radiologists in mammogram interpretation, with notable benefits for less experienced readers. These findings support the integration of AI into clinical practice, particularly in resource-limited settings where access to specialized breast radiologists is constrained.
- 7 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (5) , e0322925
Open AccessComparative analysis of diagnostic performance in mammography: A reader study on the impact of AI assistance
Purpose: This study evaluates the impact of artificial intelligence (AI) assistance on the diagnostic performance of radiologists with varying levels of experience in interpreting mammograms in a Malaysian tertiary referral center, particularly in women with dense breasts. Methods: A retrospective study including 434 digital mammograms interpreted by two general radiologists (12 and 6 years of experience) and two trainees (2 years of experience). Diagnostic performance was assessed with and without AI assistance (Lunit INSIGHT MMG), using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUC). Inter-reader agreement was measured using kappa statistics. Results: AI assistance significantly improved the diagnostic performance of all reader groups across all metrics (p < 0.05). The senior radiologist consistently achieved the highest sensitivity (86.5% without AI, 88.0% with AI) and specificity (60.5% without AI, 59.2% with AI). The junior radiologist demonstrated the highest PPV (56.9% without AI, 74.6% with AI) and NPV (90.3% without AI, 92.2% with AI). The trainees showed the lowest performance, but AI significantly enhanced their accuracy. AI assistance was particularly beneficial in interpreting mammograms of women with dense breasts. Conclusion: AI assistance significantly enhances the diagnostic accuracy and consistency of radiologists in mammogram interpretation, with notable benefits for less experienced readers. These findings support the integration of AI into clinical practice, particularly in resource-limited settings where access to specialized breast radiologists is constrained.
- Open Access
- 26 April 2024
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1-9
Application of Artificial Intelligence (AI) System in Opportunistic Screening and Diagnostic Population in a Middle-income Nation
Objective:: This study evaluates the effectiveness of artificial intelligence (AI) in mammography in a diverse population from a middle-income nation and compares it to traditional methods. Methods:: A retrospective study was conducted on 543 mammograms of 467 Malays, 48 Chinese, and 28 Indians in a middle-income nation. Three breast radiologists interpreted the examinations independently in two reading sessions (with and without AI support). Breast density and BI-RADS categories were assessed, comparing the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) results. Results:: Of 543 mammograms, 69.2% had lesions detected. Biopsies were performed on 25%(n=136), with 66(48.5%) benign and 70(51.5%) malignant. Substantial agreement in density assessment between the radiologist and AI software (κ =0.606, p < 0.001) and the BI-RADS category with and without AI (κ =0.74, p < 0.001). The performance of the AI software was comparable to the traditional methods. The sensitivity, specificity, PPV, and NPV or radiologists alone, radiologist + AI, and AI alone were 81.9%,90.4%,56.0%, and 97.1%; 81.0%, 93.1%,55.5%, and 97.0%; and 90.0%,76.5%,36.2%, and 98.1%, respectively. AI software enhances the accuracy of lesion diagnosis and reduces unnecessary biopsies, particularly for BI-RADS 4 lesions. The AI software results for synthetic were almost similar to the original 2D mammography, with AUC of 0.925 and 0.871, respectively. Conclusion:: AI software may assist in the accurate diagnosis of breast lesions, enhancing the efficiency of breast lesion diagnosis in a mixed population of opportunistic screening and diagnostic patients. Key Messages:: • The use of artificial intelligence (AI) in mammography for population-based breast cancer screening has been validated in high-income nations, with reported improved diagnostic performance. Our study evaluated the usage of an AI tool in an opportunistic screening setting in a multi-ethnic and middle-income nation. • The application of AI in mammography enhances diagnostic accuracy, potentially leading to reduced unnecessary biopsies. • AI integration into the workflow did not disrupt the performance of trained breast radiologists, as there is a substantial inter-reader agreement for BI-RADS category assessment and breast density.
- 26 April 2024
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1-9
Open AccessApplication of Artificial Intelligence (AI) System in Opportunistic Screening and Diagnostic Population in a Middle-income Nation
Objective:: This study evaluates the effectiveness of artificial intelligence (AI) in mammography in a diverse population from a middle-income nation and compares it to traditional methods. Methods:: A retrospective study was conducted on 543 mammograms of 467 Malays, 48 Chinese, and 28 Indians in a middle-income nation. Three breast radiologists interpreted the examinations independently in two reading sessions (with and without AI support). Breast density and BI-RADS categories were assessed, comparing the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) results. Results:: Of 543 mammograms, 69.2% had lesions detected. Biopsies were performed on 25%(n=136), with 66(48.5%) benign and 70(51.5%) malignant. Substantial agreement in density assessment between the radiologist and AI software (κ =0.606, p < 0.001) and the BI-RADS category with and without AI (κ =0.74, p < 0.001). The performance of the AI software was comparable to the traditional methods. The sensitivity, specificity, PPV, and NPV or radiologists alone, radiologist + AI, and AI alone were 81.9%,90.4%,56.0%, and 97.1%; 81.0%, 93.1%,55.5%, and 97.0%; and 90.0%,76.5%,36.2%, and 98.1%, respectively. AI software enhances the accuracy of lesion diagnosis and reduces unnecessary biopsies, particularly for BI-RADS 4 lesions. The AI software results for synthetic were almost similar to the original 2D mammography, with AUC of 0.925 and 0.871, respectively. Conclusion:: AI software may assist in the accurate diagnosis of breast lesions, enhancing the efficiency of breast lesion diagnosis in a mixed population of opportunistic screening and diagnostic patients. Key Messages:: • The use of artificial intelligence (AI) in mammography for population-based breast cancer screening has been validated in high-income nations, with reported improved diagnostic performance. Our study evaluated the usage of an AI tool in an opportunistic screening setting in a multi-ethnic and middle-income nation. • The application of AI in mammography enhances diagnostic accuracy, potentially leading to reduced unnecessary biopsies. • AI integration into the workflow did not disrupt the performance of trained breast radiologists, as there is a substantial inter-reader agreement for BI-RADS category assessment and breast density.
- 10 January 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79  (4) , e524-e531
Abbreviated breast magnetic resonance imaging (MRI) or digital breast tomosynthesis for breast cancer detection in dense breasts? A retrospective preliminary study with comparable results
- 10 January 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79  (4) , e524-e531
Abbreviated breast magnetic resonance imaging (MRI) or digital breast tomosynthesis for breast cancer detection in dense breasts? A retrospective preliminary study with comparable results
- Open Access
- 25 October 2023
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1
Clinical Usefulness of Abbreviated MRI Protocol in Breast Cancer Detection
Background: The use of breast MRI for screening has increased over the past decade, mostly in women with a high risk of breast cancer. Abbreviated breast MRI (AB-MR) is introduced to make MRI a more accessible screening modality. AB-MR decreases scanning and reporting time and the overall cost of MRI. Objective: This study aims to evaluate the diagnostic efficacy of abbreviated MRI protocol in detecting breast cancer in screening and diagnostic populations, using histopathology as the reference standard. Materials and Methods: This is a single-centre retrospective cross-sectional study of 134 patients with 198 histologically proven breast lesions who underwent full diagnostic protocol contrast-enhanced breast MRI (FDP-MR) at the University Malaya Medical Centre (UMMC) from 1st January 2018 to 31st December 2019. AB-MR was pre-determined and evaluated with regard to the potential to detect and exclude malignancy from 3 readers of varying radiological experiences. The sensitivity of both AB-MR and FDP-MR were compared using the McNemar test, where both protocols' diagnostic performances were assessed via the receiver operating characteristic (ROC) curve. Inter-observer agreement was analysed using Fleiss Kappa. Results: There were 134 patients with 198 lesions. The average age was 50.9 years old (range 27 – 80). A total of 121 (90%) MRIs were performed for diagnostic purposes. Screening accounted for 9.4% of the cases, 55.6% (n=110) lesions were benign, and 44.4% (n=88) were malignant. The commonest benign and malignant lesions were fibrocystic change (27.3%) and invasive ductal carcinoma (78.4%). The mean sensitivity, specificity, positive predictive value, and negative predictive value for AB-MR were 0.96, 0.57, 0.68 and 0.94, respectively. Both AB-MR and FDP-MR showed excellent diagnostic performance with AUC of 0.88 and 0.96, respectively. The general inter-observer agreement of all three readers for AB-MR was substantial (k=0.69), with fair agreement demonstrated between AB-MR and FDP-MR (k=0.36). Conclusion: The study shows no evidence that the diagnostic efficacy of AB-MR is inferior to FDP-MR. AB-MR, with high sensitivity, has proven its capability in cancer detection and exclusion, especially for biologically aggressive cancers.
- 25 October 2023
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1
Open AccessClinical Usefulness of Abbreviated MRI Protocol in Breast Cancer Detection
Background: The use of breast MRI for screening has increased over the past decade, mostly in women with a high risk of breast cancer. Abbreviated breast MRI (AB-MR) is introduced to make MRI a more accessible screening modality. AB-MR decreases scanning and reporting time and the overall cost of MRI. Objective: This study aims to evaluate the diagnostic efficacy of abbreviated MRI protocol in detecting breast cancer in screening and diagnostic populations, using histopathology as the reference standard. Materials and Methods: This is a single-centre retrospective cross-sectional study of 134 patients with 198 histologically proven breast lesions who underwent full diagnostic protocol contrast-enhanced breast MRI (FDP-MR) at the University Malaya Medical Centre (UMMC) from 1st January 2018 to 31st December 2019. AB-MR was pre-determined and evaluated with regard to the potential to detect and exclude malignancy from 3 readers of varying radiological experiences. The sensitivity of both AB-MR and FDP-MR were compared using the McNemar test, where both protocols' diagnostic performances were assessed via the receiver operating characteristic (ROC) curve. Inter-observer agreement was analysed using Fleiss Kappa. Results: There were 134 patients with 198 lesions. The average age was 50.9 years old (range 27 – 80). A total of 121 (90%) MRIs were performed for diagnostic purposes. Screening accounted for 9.4% of the cases, 55.6% (n=110) lesions were benign, and 44.4% (n=88) were malignant. The commonest benign and malignant lesions were fibrocystic change (27.3%) and invasive ductal carcinoma (78.4%). The mean sensitivity, specificity, positive predictive value, and negative predictive value for AB-MR were 0.96, 0.57, 0.68 and 0.94, respectively. Both AB-MR and FDP-MR showed excellent diagnostic performance with AUC of 0.88 and 0.96, respectively. The general inter-observer agreement of all three readers for AB-MR was substantial (k=0.69), with fair agreement demonstrated between AB-MR and FDP-MR (k=0.36). Conclusion: The study shows no evidence that the diagnostic efficacy of AB-MR is inferior to FDP-MR. AB-MR, with high sensitivity, has proven its capability in cancer detection and exclusion, especially for biologically aggressive cancers.
- Open Access
- 25 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18  (8) , e0290772
Magnetic resonance imaging features of invasive breast cancer association with the tumour stromal ratio
Objective: To assess the association between breast cancer tumour stroma and magnetic resonance imaging (MRI) features. Materials and methods: A total of 84 patients with treatment-naïve invasive breast cancer were enrolled into this retrospective study. The tumour stroma ratio (TSR) was estimated from the amount of tumour stroma in the pathology specimen of the breast tumour. The MRI images of the patients were analysed based on Breast Imaging Reporting and Data Systems (ACR-BIRADS) for qualitative features which include T2- weighted, diffusion-weighted images (DWI) and dynamic contrast-enhanced (DCE) for kinetic features. The mean signal intensity (SI) of Short Tau Inversion Recovery (STIR), with the ratio of STIR of the lesion and pectoralis muscle (L/M ratio) and apparent diffusion coefficient (ADC) value, were measured for the quantitative features. Correlation tests were performed to assess the relationship between TSR and MRI features. Results: There was a significant correlation between the margin of mass, enhancement pattern, and STIR signal intensity of breast cancer and TSR. There were 54.76% (n = 46) in the low stromal group and 45.24% (n = 38) in the high stromal group. A significant association were seen between the margin of the mass and TSR (p = 0.034) between the L/M ratio (p <0.001), and between STIR SI of the lesion and TSR (p<0.001). The median L/M ratio was significantly higher in the high TSR group as compared to the lower TSR group (p < 0.001). Conclusion: Breast cancer with high stroma had spiculated margins, lower STIR signal intensity, and a heterogeneous pattern of enhancement. Hence, in this preliminary study, certain MRI features showed a potential to predict TSR.
- 25 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18  (8) , e0290772
Open AccessMagnetic resonance imaging features of invasive breast cancer association with the tumour stromal ratio
Objective: To assess the association between breast cancer tumour stroma and magnetic resonance imaging (MRI) features. Materials and methods: A total of 84 patients with treatment-naïve invasive breast cancer were enrolled into this retrospective study. The tumour stroma ratio (TSR) was estimated from the amount of tumour stroma in the pathology specimen of the breast tumour. The MRI images of the patients were analysed based on Breast Imaging Reporting and Data Systems (ACR-BIRADS) for qualitative features which include T2- weighted, diffusion-weighted images (DWI) and dynamic contrast-enhanced (DCE) for kinetic features. The mean signal intensity (SI) of Short Tau Inversion Recovery (STIR), with the ratio of STIR of the lesion and pectoralis muscle (L/M ratio) and apparent diffusion coefficient (ADC) value, were measured for the quantitative features. Correlation tests were performed to assess the relationship between TSR and MRI features. Results: There was a significant correlation between the margin of mass, enhancement pattern, and STIR signal intensity of breast cancer and TSR. There were 54.76% (n = 46) in the low stromal group and 45.24% (n = 38) in the high stromal group. A significant association were seen between the margin of the mass and TSR (p = 0.034) between the L/M ratio (p <0.001), and between STIR SI of the lesion and TSR (p<0.001). The median L/M ratio was significantly higher in the high TSR group as compared to the lower TSR group (p < 0.001). Conclusion: Breast cancer with high stroma had spiculated margins, lower STIR signal intensity, and a heterogeneous pattern of enhancement. Hence, in this preliminary study, certain MRI features showed a potential to predict TSR.
- 23 March 2023
- Published by Elsevier in Clinical Radiology
- Vol. 78  (6) , 444-450
The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions
- 23 March 2023
- Published by Elsevier in Clinical Radiology
- Vol. 78  (6) , 444-450
The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 18  (13) , 1347-1361
MRI Breast: Current Imaging Trends, Clinical Applications, and Future Research Directions
Magnetic Resonance Imaging (MRI) is the most sensitive and advanced imaging technique in diagnosing breast cancer and is essential in improving cancer detection, lesion characterization, and determining therapy response. In addition to the dynamic contrast-enhanced (DCE) technique, functional techniques such as magnetic resonance spectroscopy (MRS), diffusion-weighted imaging (DWI), diffusion kurtosis imaging (DKI), and intravoxel incoherent motion (IVIM) further characterize and differentiate benign and malignant lesions thus, improving diagnostic accuracy. There is now an increasing clinical usage of MRI breast, including screening in high risk and supplementary screening tools in average-risk patients. MRI is becoming imperative in assisting breast surgeons in planning breast-conserving surgery for preoperative local staging and evaluation of neoadjuvant chemotherapy response. Other clinical applications for MRI breast include occult breast cancer detection, investigation of nipple discharge, and breast implant assessment. There is now an abundance of research publications on MRI Breast with several areas that still remain to be explored. This review gives a comprehensive overview of the clinical trends of MRI breast with emphasis on imaging features and interpretation using conventional and advanced techniques. In addition, future research areas in MRI breast include developing techniques to make MRI more accessible and costeffective for screening. The abbreviated MRI breast procedure and an area of focused research in the enhancement of radiologists' work with artificial intelligence have high impact for the future in MRI Breast.
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 18  (13) , 1347-1361
MRI Breast: Current Imaging Trends, Clinical Applications, and Future Research Directions
Magnetic Resonance Imaging (MRI) is the most sensitive and advanced imaging technique in diagnosing breast cancer and is essential in improving cancer detection, lesion characterization, and determining therapy response. In addition to the dynamic contrast-enhanced (DCE) technique, functional techniques such as magnetic resonance spectroscopy (MRS), diffusion-weighted imaging (DWI), diffusion kurtosis imaging (DKI), and intravoxel incoherent motion (IVIM) further characterize and differentiate benign and malignant lesions thus, improving diagnostic accuracy. There is now an increasing clinical usage of MRI breast, including screening in high risk and supplementary screening tools in average-risk patients. MRI is becoming imperative in assisting breast surgeons in planning breast-conserving surgery for preoperative local staging and evaluation of neoadjuvant chemotherapy response. Other clinical applications for MRI breast include occult breast cancer detection, investigation of nipple discharge, and breast implant assessment. There is now an abundance of research publications on MRI Breast with several areas that still remain to be explored. This review gives a comprehensive overview of the clinical trends of MRI breast with emphasis on imaging features and interpretation using conventional and advanced techniques. In addition, future research areas in MRI breast include developing techniques to make MRI more accessible and costeffective for screening. The abbreviated MRI breast procedure and an area of focused research in the enhancement of radiologists' work with artificial intelligence have high impact for the future in MRI Breast.
- Open Access
- 18 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17  (10) , e0274385
Impact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer
We looked at the usefulness of magnetic resonance imaging (MRI) in decision-making and surgical management of patients selected for intraoperative radiotherapy (IORT). We also compared lesion size measurements in different modalities (ultrasound (US), mammogram (MMG), MRI) against pathological size as the gold standard. 63 patients eligible for IORT based on clinical and imaging criteria over a 34-month period were enrolled. All had MMG and US, while 42 had additional preoperative MRI for locoregional preoperative staging. Imaging findings and pathological size concordances were analysed across the three modalities. MRI changed the surgical management of 5 patients (11.9%) whereby breast-conserving surgery (BCS) and IORT was cancelled due to detection of satellite lesion, tumor size exceeding 30mm and detection of axillary nodal metastases. Ten of 42 patients (23.8%) who underwent preoperative MRI were subjected to additional external beam radiotherapy (EBRT); 7 due to lymphovascular invasion (LVI), 2 due to involved margins, and 1 due to axillary lymph node metastatic carcinoma detected in the surgical specimen. Five of 21 (23.8%) patients without prior MRI were subjected to additional EBRT post-surgery; 3 had LVI and 2 had involved margins. The rest underwent BCS and IORT as planned. MRI and MMG show better imaging-pathological size correlation. Significant increase in the mean ‘waiting time’ were seen in the MRI group (34.1 days) compared to the conventional imaging group (24.4 days). MRI is a useful adjunct to conventional imaging and impacts decision making in IORT. It is also the best imaging modality to determine the actual tumour size.
- 18 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17  (10) , e0274385
Open AccessImpact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer
We looked at the usefulness of magnetic resonance imaging (MRI) in decision-making and surgical management of patients selected for intraoperative radiotherapy (IORT). We also compared lesion size measurements in different modalities (ultrasound (US), mammogram (MMG), MRI) against pathological size as the gold standard. 63 patients eligible for IORT based on clinical and imaging criteria over a 34-month period were enrolled. All had MMG and US, while 42 had additional preoperative MRI for locoregional preoperative staging. Imaging findings and pathological size concordances were analysed across the three modalities. MRI changed the surgical management of 5 patients (11.9%) whereby breast-conserving surgery (BCS) and IORT was cancelled due to detection of satellite lesion, tumor size exceeding 30mm and detection of axillary nodal metastases. Ten of 42 patients (23.8%) who underwent preoperative MRI were subjected to additional external beam radiotherapy (EBRT); 7 due to lymphovascular invasion (LVI), 2 due to involved margins, and 1 due to axillary lymph node metastatic carcinoma detected in the surgical specimen. Five of 21 (23.8%) patients without prior MRI were subjected to additional EBRT post-surgery; 3 had LVI and 2 had involved margins. The rest underwent BCS and IORT as planned. MRI and MMG show better imaging-pathological size correlation. Significant increase in the mean ‘waiting time’ were seen in the MRI group (34.1 days) compared to the conventional imaging group (24.4 days). MRI is a useful adjunct to conventional imaging and impacts decision making in IORT. It is also the best imaging modality to determine the actual tumour size.
- Open Access
- 28 February 2022
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 22  (1) , 138-143
Pulmonary Complications of COVID-19: A case report
Rapid evolution of pulmonary complications associated with severe COVID-19 pneumonia often pose a management challenge to clinicians especially in the critical care setting. Serial chest imaging enable clinicians to better monitor disease progression and identify potential complications early which may decrease the mortality and morbidity associated with COVID-19. We report a 69-year-old male patient with severe COVID-19 pneumonia who presented to a tertiary referral centre in Kuala Lumpur, Malaysia, in 2020 with multiple pulmonary complications including lung cavitation, bronchopleural fistula, pneumothorax, pneumomediastinum, subcutaneous emphysema and acute pulmonary embolism. Unfortunately, the patient died one month after admission. COVID-19 patients may develop pulmonary complications due to a combination of direct viral lung damage, hypoxaemia and high stress ventilation. Awareness of COVID-19 complications can prompt early diagnosis and timely management to reduce morbidity and mortality.
- 28 February 2022
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 22  (1) , 138-143
Open AccessPulmonary Complications of COVID-19: A case report
Rapid evolution of pulmonary complications associated with severe COVID-19 pneumonia often pose a management challenge to clinicians especially in the critical care setting. Serial chest imaging enable clinicians to better monitor disease progression and identify potential complications early which may decrease the mortality and morbidity associated with COVID-19. We report a 69-year-old male patient with severe COVID-19 pneumonia who presented to a tertiary referral centre in Kuala Lumpur, Malaysia, in 2020 with multiple pulmonary complications including lung cavitation, bronchopleural fistula, pneumothorax, pneumomediastinum, subcutaneous emphysema and acute pulmonary embolism. Unfortunately, the patient died one month after admission. COVID-19 patients may develop pulmonary complications due to a combination of direct viral lung damage, hypoxaemia and high stress ventilation. Awareness of COVID-19 complications can prompt early diagnosis and timely management to reduce morbidity and mortality.